Atrial fibrillation and mortality in African American patients with heart failure: Results from the African American Heart Failure Trial (A-HeFT)

American Heart Journal

Volumn 162, Issue 1, 2011, Pages 154-159

  Mitchell, Judith E ^a   Tam, S William ^b   Trivedi, Kamini ^b   Taylor, Anne L ^c   O'Neal, Welton ^d   Cohn, Jay N ^e   Worcel, Manuel ^b  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

^b Medical Center ^*

^c Och Spine at New York Presbyterian Hospitals   (United States)

^d TAKEDA PHARMACEUTICALS   (United States)

^e UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; CREATININE; DIGITALIS GLYCOSIDE; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDRALAZINE PLUS ISOSORBIDE DINITRATE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PLACEBO; SPIRONOLACTONE;

ADULT; AFRICAN AMERICAN; AGED; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; DRUG DOSE TITRATION; EVENT FREE SURVIVAL; FEMALE; HEART ATRIUM FIBRILLATION; HEART EJECTION FRACTION; HEART FAILURE; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; REVIEW; SYSTOLIC BLOOD PRESSURE;

EID: 79960168180     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2011.04.022     Document Type: Article

References (33)

1. K. Swedberg, L.G. Olsson, and A. Charlesworth Prognostic relevance of atrial fibrillation in patients with chronic heart failure on long-term treatment with beta-blockers: results from COMET Eur Heart J 26 2005 1303 1308 (Pubitemid 41435461)
2. L.G. Olsson, K. Swedberg, A. Ducharme for the CHARM Investigators Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction: results from the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) program J Am Coll Cardiol 47 2006 1997 2004
3. A. Ahmed, P. Thornton, and G.J. Perry Impact of atrial fibrillation on mortality and readmission in older adults hospitalized with heart failure Eur J Heart Fail 6 2004 421 426 (Pubitemid 38746584)
4. G.P. Kelley, M.A. Stellingworth, and S. Broyles Electrocardiographic findings in 888 patients > or = 90 years of age Am J Cardiol 98 2006 1512 1514 (Pubitemid 44779484)
5. B. Ruo, A.M. Capra, and N.G. Jensvold Racial variation in the prevalence of atrial fibrillation among patients with heart failure: the Epidemiology, Practice, Outcomes, and Costs of Heart Failure (EPOCH) study J Am Coll Cardiol 43 2004 429 435 (Pubitemid 38167704)
6. C.B. Upshaw Jr Reduced prevalence of atrial fibrillation in black patients compared with white patients attending an urban hospital: an electrocardiographic study J Natl Med Assoc 94 2002 204 208
7. A.L. Taylor, S. Ziesche, C. Yancy for the African-American Heart Failure Trial Investigators Combination of isosorbide dinitrate and hydralazine in blacks with heart failure N Engl J Med 351 2004 2049 2057
8. J.A. Franciosa, A.L. Taylor, J.N. Cohn for the A-HeFT Investigators African-American Heart Failure Trial (A-HeFT): rationale, design, and methodology J Card Fail 8 2002 128 135 (Pubitemid 34857277)
9. A.L. Taylor, S. Ziesche, and C.W. Yancy Early and sustained benefit on event-free survival and heart failure hospitalization from fixed-dose combination of isosorbide dinitrate/hydralazine: consistency across subgroups in the African-American heart failure trial Circulation 115 2007 1747 1753 (Pubitemid 46648611)
10. J.N. Cohn, S.W. Tam, and I.S. Anand Isosorbide dinitrate and hydralazine in a fixed-dose combination produces further regression of left ventricular remodeling in a well-treated black population with heart failure: results from A-HeFT J Card Fail 13 2007 331 339 (Pubitemid 46978420)
11. I.S. Anand, S.W. Tam, and T.S. Rector Influence of blood pressure on the effectiveness of fixed-dose combination of isosorbide dinitrate and hydralazine in the African-American heart failure trial J Am Coll Cardiol 49 2007 32 39 (Pubitemid 46026903)
12. P.A. Poole-Wilson, K. Swedberg, and J.G. Cleland Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomized controlled trial Lancet 362 2003 7 13 (Pubitemid 36835815)
13. J.E. Mitchell, A.S. HellKamp, D.B. Mark for the SCD-HeFT Investigators Observations regarding outcome in minorities in the sudden cardiac death in heart failure trial Am Heart J 155 2008 501 506
14. K.F. Adams Jr., G.C. Fonarow, C.L. Emerman for the ADHERE Scientific Advisory Committee and investigators. ADHERE: characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE) Am Heart J 149 2005 209 216 (Pubitemid 40348525)
15. G.C. Fonarow, W.T. Abraham, N.M. Albert for the OPTIMIZE-HF Investigators and Hospitals OPTIMIZE-HF: association between performance measures and clinical outcomes for patients hospitalized with heart failure JAMA 297 2007 61 70 (Pubitemid 46041727)
16. J.E. Mitchell, M. Caboral, and J. Feng Observations regarding atrial fibrillation/flutter in black patients with heart failure J Am Coll Cardiol 49 No. 9, Supplement A 2007 22A
17. G.M. Marcus, A. Alonso, and C.A. Peralta European ancestry as a risk factor for atrial fibrillation in African Americans Circulation 122 2010 2009 2015
18. A.S. Go, E.M. Hylek, and K.A. Phillips Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study JAMA 285 2001 2370 2375 (Pubitemid 32424106)
19. E.J. Benjamin, P.A. Wolf, and R.B. D'Agostina Impact of atrial fibrillation on the risk of death the Framingham Heart Study Circulation 98 1998 946 953
20. M. Rienstra, D.J. Van Veldhuisen, and V.E. Hagens Gender-related differences in rhythm control treatment in persistent atrial fibrillationdata of the Rate Control versus Electrical Cardioversion (RACE) study J Am Coll Cardiol 46 2005 1298 1306 (Pubitemid 41615553)
21. K.H. Humphries, C.R. Kerr, and S.J. Connolly New-onset atrial fibrillation, sex differences in presentation, treatment and outcome Circulation 103 2001 2365 2370 (Pubitemid 32448801)
22. O. Adam, G. Frost, and F. Custodis Role of Rac1 GTPase activation in atrial fibrillation J Am Coll Cardiol 50 2007 359 367 (Pubitemid 47064499)
23. S.C. Dudley Jr, N.E. Hoch, and L.A. McCann Atrial fibrillation increases production of superoxide by the left atrium and left atrial appendage: role of the NADPH and xanthine oxidases Circulation 112 2005 1266 1273 (Pubitemid 41268651)
24. M.J. Mihm, F. Yu, and C.A. Carnes Impaired myofibrillar energetics and oxidative injury during human atrial fibrillation Circulation 104 2001 174 180 (Pubitemid 32655834)
25. H. Cai, Z. Li, and A. Goette Downregulation of endocardial nitric oxide synthase expression and nitric oxide production in atrial fibrillation: potential mechanisms for atrial thrombosis and stroke Circulation 106 2002 2854 2858 (Pubitemid 35396987)
26. T. Minamino, M. Kitakaze, and S. Sanada Increased expression of P-selectin on platelets is a risk factor for silent cerebral infarction in patients with atrial fibrillation: role of nitric oxide Circulation 98 1998 1721 1727 (Pubitemid 28492491)
27. M. Guazzi, and R. Arena Endothelial dysfunction and pathophysiological correlates in atrial fibrillation Heart 95 2009 102 106
28. E.I. Skalidis, E.A. Zacharis, and D.K. Tsetis Endothelial cell function during atrial fibrillation and after restoration of sinus rhythm Am J Cardiol 99 2007 1258 1262 (Pubitemid 46659865)
29. D. Nikitovic, E.A. Zacharis, and E.G. Manios Plasma levels of nitrites/nitrates in patients with chronic atrial fibrillation are increased after electrical restoration of sinus rhythm J Interv Card Electrophysiol 7 2002 171 176 (Pubitemid 35462314)
30. S. Fujii, Y. Suzuki, and T. Yoshimura In vivo three-dimensional EPR imaging of nitric oxide production from isosorbide dinitrate in mice Am J Physiol 274 1998 G857 G862
31. P. Rauhala, and C.C. Chiueh Effects of atypical antioxidative agents, S-nitrosoglutathione and manganese, on brain lipid peroxidation induced by iron leaking from tissue disruption Ann N Y Acad Sci 899 2000 238 254 (Pubitemid 30352790)
32. T. Münzel, S. Kurz, and S. Rajagopalan Hydralazine prevents nitroglycerin tolerance by inhibiting activation of a membrane-bound NADH oxidase: a new action for an old drug J Clin Investig 98 1996 1465 1470 (Pubitemid 26322073)
33. T. Münzel, and D.G. Harrison Increased superoxide in heart failure. A biochemical baroreflex gone awry Circulation 100 1999 216 218 (Pubitemid 29340123)